Skip to content
lifestyle.trondstidkontroll.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
DECHRA PHARMACEUTICALS LIMITED
Dechra Announces FDA Approval of CosACTHen® (cosyntropin injection), the First and Only Cosyntropin Approved Specifically for Canine Patients
May 21, 2026
Dechra to Establish Global Headquarters in Boston, Strengthening U.S. Leadership and Innovation Presence
March 11, 2026
Dechra Announces Veterinary Oral Health Council (VOHC®) Acceptance of VETRADENT® Dental Wipes for Dogs, Recognizing Proven Tartar Control Performance
February 26, 2026